Stem cells from umbilical cord blood may help treat eczema

A new study suggests that treatment with stem cells from umbilical cord blood might be an effective therapy for patients with moderate-to-severe eczema, or atopic dermatitis.

For the clinical trial, 34 patients were randomly assigned to receive a low dose or of the cells subcutaneously. Fifty five percent of patients who received the high dose showed a 50% reduction in what's known as the Eczema Area and Severity Index score at week 12. Immune-related markers of also decreased significantly.

"This study is a first-in-class study demonstrating that adults with moderate-to-severe atopic dermatitis responded to a treatment of stem cells derived from ," said Dr. Tae-Yoon Kim, senior author of the Stem Cells study. "The single treatment of stem cells in patients resulted in the significant and persistent improvement in disease symptoms throughout the follow-up period of 12 weeks."


Explore further

Human breast milk effective for atopic dermatitis in infants

More information: Hyung-Sik Kim et al, Clinical Trial of Human Umbilical Cord Blood-derived Stem Cells for the Treatment of Moderate-to-Severe Atopic Dermatitis: Phase I/IIa Studies, STEM CELLS (2016). DOI: 10.1002/stem.2401
Journal information: Stem Cells

Provided by Wiley
Citation: Stem cells from umbilical cord blood may help treat eczema (2016, June 7) retrieved 13 December 2019 from https://medicalxpress.com/news/2016-06-stem-cells-umbilical-cord-blood.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
4 shares

Feedback to editors

User comments